Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs Cyclosporine in VKC
NCT01068054Phase 3Completed
- Sponsor
- Siriraj Hospital
- Start
- Jun 2003
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Tacrolimus Ointment 0.1% Iwaki in Vernal Keratoconjunctivitis (VKC) (2 arms), sponsored by Siriraj Hospital. Primary endpoint: Overall subjective ocular symptom scores at 8 weeks. Started Jun 2003; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on NCT01068054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01068054.